Bristol Myers Squibb (BMS) is a global biopharmaceutical leader focused on discovering, developing, and delivering innovative treatments for serious conditions such as cancer, cardiovascular diseases, and immune disorders. BMS combines advanced research with a patient-centered approach, aiming to transform lives through science. With a robust R&D pipeline and commitment to sustainability and ESG practices, BMS creates value for both patients and shareholders, advancing health globally.